FORT WORTH, Texas (BUSINESS WIRE) NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle (LSAM) investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.The DDW poster entitled “Intracystic Injecti.